Keywords: آدنوکارسینوم ریه; Adenocarcinoma of the lung; Epidermal growth factor receptor; lung cancer; Mutation; non-small-cell lung cancer; targeted therapy;
مقالات ISI آدنوکارسینوم ریه (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Phase II Trial of Dose-dense Pemetrexed, Gemcitabine, and Bevacizumab in Patients With Advanced, Non-Small-cell Lung Cancer
Keywords: آدنوکارسینوم ریه; Adenocarcinoma of the lung; Dose-dense chemotherapy; Frontline chemotherapy; Nonplatinum; VEGF inhibition;
PD-L1 expression is associated with epithelial-to-mesenchymal transition in adenocarcinoma of the lung
Keywords: آدنوکارسینوم ریه; Programmed cell death 1; Programmed cell death 1 ligand 1; Epithelial-mesenchymal transition; Adenocarcinoma of the lung; Immune checkpoint; Cancer immunotherapy
Intratumoral distribution of EGFR-amplified and EGFR-mutated cells in pulmonary adenocarcinoma
Keywords: آدنوکارسینوم ریه; Epidermal growth factor receptor; Adenocarcinoma of the lung; Chromogenic in situ hybridization
Accumulation of genomic alterations in 2p16, 9q33.1 and 19p13 in lung tumours of asbestos-exposed patients
Keywords: آدنوکارسینوم ریه; Lung cancer; Asbestos exposure; Pulmonary epithelium; Allelic imbalance; DNA copy number alteration; LC; lung cancer; AI; allelic imbalance; CNA; copy number alteration; LOH; loss of heterozygosity; FF; fresh frozen; FFPE; formalin-fixed paraffin-embedded
The utility of the proposed IASLC/ATS/ERS lung adenocarcinoma subtypes for disease prognosis and correlation of driver gene alterations
Keywords: آدنوکارسینوم ریه; IASLC classification; Adenocarcinoma of the lung; ALK; EGFR; KRAS
Miliary Never-Smoking Adenocarcinoma of the Lung: Strong Association with Epidermal Growth Factor Receptor Exon 19 Deletion
Keywords: آدنوکارسینوم ریه; Adenocarcinoma of the lung; EGFR exon 19 deletion; EGFR tyrosine kinase inhibitor; Miliary lung metastases; Never smoker
Expression of histone deacetylase 1 correlates with a poor prognosis in patients with adenocarcinoma of the lung
Keywords: آدنوکارسینوم ریه; HDAC1; Prognosis; Clinicopathological factor; RT-PCR; Adenocarcinoma of the lung
Epidermal growth factor receptor tyrosine kinase inhibitors as a first-line therapy for never-smokers with adenocarcinoma of the lung having asymptomatic synchronous brain metastasis
Keywords: آدنوکارسینوم ریه; Epidermal growth factor receptor tyrosine kinase inhibitor; Brain metastasis; Never-smoker; Adenocarcinoma of the lung
Lectin histochemistry of metastatic adenocarcinomas of the lung
Keywords: آدنوکارسینوم ریه; Adenocarcinoma of the lung; Lymph node metastases; Haematogenous metastases; Lectins; HPA; UEA-I; PHA-L
Interaction between CYP1A2-T2467DELT polymorphism and smoking in adenocarcinoma and squamous cell carcinoma of the lung
Keywords: آدنوکارسینوم ریه; CYP1A2, cytochrome P450 1A2; CI, confidence interval; OR, odds ratio; SCC, squamous-cell carcinomaSmoke; Carcinogens’ activation; CYP1A2-T2467delT genotype; Adenocarcinoma of the lung; Squamous cell carcinoma of the lung; Case-only study; Genetic suscepti
Elevated risk of squamous-cell carcinoma of the lung in heavy smokers carrying the variant alleles of the TP53 Arg72Pro and p21 Ser31Arg polymorphisms
Keywords: آدنوکارسینوم ریه; p21; CDKN1A (Waf1, cip1); SCC; squamous-cell carcinoma; OR; odds ratio; CI; confidence interval; Cell cycle control; Molecular epidemiology; Genotype; Adenocarcinoma of the lung; DNA repair;
The Role of Gefitinib Treatment for Korean Never-Smokers with Advanced or Metastatic Adenocarcinoma of the Lung: A Prospective Study
Keywords: آدنوکارسینوم ریه; Gefitinib; Never-smoker; Adenocarcinoma of the lung
Epidermal growth factor receptor abnormalities in lung cancer. Pathogenetic and clinical implications
Keywords: آدنوکارسینوم ریه; EGFR; Adenocarcinoma of the lung; Mutation; Gene amplification; Atypical adenomatous hyperplasia; Normal epithelium